Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Thumbnail

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

The Disrupt BTK II study will include 250 patients overall. 

Thumbnail

PAD specialists announce new FDA clearance for image-guided atherectomy system

The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.

Thumbnail

New risk calculator detects TEER patients who may need to be readmitted for HF

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

New survey examines the biggest issues impacting care for CAD, PAD patients

Physicians, industry leaders—and, yes, patients themselves—provided an updated look at the state of vascular care in 2021. 

Thumbnail

New intravascular ultrasound study reveals ‘clear opportunity’ to help millions

This is a moment for us to further our efforts in saving lives and saving limbs,” one Beth Israel Deaconess Medical Center expert said recently.

‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS

The Smith Center for Outcomes Research in Cardiology examined real-world data from more than 700,000 CMS patients. The group's findings were presented during TCT 2021. 

Thumbnail

TMVR with transfemoral access a 'promising option,’ early data suggest

Researchers reported at TCT 2021 that survival was 100% after 30 days.

Thumbnail

5 years later, TAVR still delivering strong results for intermediate-risk patients

Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years.